a: Schematic: dark-room fixation trials, each with the same 4-sec ‘fixate’ epochs but in blocks of different trial periods, short (8-sec, blue) and long (20-sec; pink; same colour scheme in other panels & Fig 4). b, c: ‘Blood volume’ signal, short and long trials respectively. Averages triggered on trial onsets, +/− SEM (b: n=220 trials; c: N=179). Arrowheads: peak brightening (red), darkening (black). Dotted white line in panel c shows where short trial onset would have occurred. d: population histograms of peak brightening and darkening in units of trial phase (0=trial start, 1=trial end, start of next trial; brightening: mean=0.43, sd=0.16; darkening, mean=0.89, sd=0.21; N=66; Trial periods ranging from 6 to 30 sec). e, f: Signal at transitions between trial periods: short-to-long (e; N=16 trials, mean+/− SEM), and long-to-short (f: N=10); arrowheads are aligned, in each case, to the panel above for comparison of signal features. Dotted white line as in c. g: Left: Short-to-Long transition trial (green) is statistically indistinguishable from other short trials over one short-trial period (blue background). (Bootstrap analysis. Green: mean transition trial; grey: means of 500 random N=16-trial subsets of the short trials to match statistics of transition trial; black: grand mean of all short trials, same as b; inset histogram: correlation of random subsets with grand mean; arrowhead: correlation of transition trial with grand mean = 0.97). Right: Short-to-Long transition response is distinct from random N=16-trial subsets of long trials. Same conventions as on the left, with the correlation coefficients being calculated, again, over the duration of one short period (pink background).